Nicotine Mini

Product NDC: 11822-3315
11-digit product format: 118223315
Labeler code: 11822
Product ID: 11822-3315_78461243-4284-4481-b079-b2235a5c700c
Type: HUMAN OTC DRUG
Nonproprietary name: nicotine polacrilex
Dosage form: LOZENGE
Route: ORAL
Labeler: Rite Aid Corporation
Application: ANDA207868
Marketing category: ANDA
Marketing start: 2019-12-27
Marketing end: 2026-12-27
Substance: NICOTINE
Active strength: 2 mg/1
Pharmacologic classes: Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
NDC exclude flag: No
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A207868-001	NICOTINE POLACRILEX	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL			2019-02-07
A207868-002	NICOTINE POLACRILEX	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL			2019-02-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A207868-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A207868-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2019-02-07	`782e0a99824c…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A207868-001	PC	2019-10-01	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A207868-002	PC	2019-10-01	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A207868-001	PC	2019-10-01	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A207868-002	PC	2019-10-01	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A207868-001	PC	2019-10-01	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A207868-002	PC	2019-10-01	`b00525d2431f…`

Additional Listing Data#

Finished product: Yes
Brand name base: Nicotine Mini

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NICOTINE	2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6M3C89ZY6R	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
359817	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
876b80a3-3ea8-4821-9716-c18e24502822	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
11822-3315-1	2023-02-21	C162847	48780-1	f386c649-c3f9-0266-e053-dadaa90a7c1a	Drug Facts
11822-3315-1	2023-01-30	C162847	48780-1	f386c649-c3f9-0266-e053-dadaa90a7c1a	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
11822-3315-1	Nicotine Mini	3 in 1 BOX	LOZENGE	3		4
11822-3315-1	Nicotine Mini	27 in 1 BOTTLE, PLASTIC	LOZENGE	27		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
11822-3315	NICOTINE MINI (NICOTINE POLACRILEX) LOZENGE [RITE AID CORPORATION]	3	Current NDC, Legacy NDC, 2 package rows	20230222_876b80a3-3ea8-4821-9716-c18e24502822.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 26 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mini Nicotine	NICOTINE POLACRILEX	WALMART INC. (see also Equate)	286e2768-ad98-43be-a3be-a2db0370f50f	2026-07-09	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	WALMART INC. (see also Equate)	b49546cd-6cc4-422c-9a72-3a1faf2abcd3	2026-07-09	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	P & L Development, LLC	b105adbd-b306-4944-a1d8-f209b74606c9	2026-06-24	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	P & L Development, LLC	9ddc3fde-f384-41d2-93d5-077b6e419029	2026-06-24	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	Walgreens	dfdd100d-8808-40f4-a68e-1e0388be424d	2026-05-08	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	Walgreens	60551e9a-c82f-45ce-8ef4-03c00c6c870a	2026-05-06	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	HC Jones, Inc.	d0d1a5ef-fd4c-4854-9453-68808cc0fab0	2026-04-07	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	HC Jones, Inc.	ff9e34ff-5086-4e1b-9220-27ac2ac1069c	2026-04-07	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Sugar Free	NICOTINE POLACRILEX	CVS Pharmacy	9a96ba38-e696-4465-9869-9b269dc18f8d	2026-01-27	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	Rising Pharma Holdings, Inc.	05990040-5bd7-4622-8fe3-2d7573904dfa	2025-12-06	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	Rugby Laboratories, Inc.	237471f8-ce0f-423b-993f-b4380fd890ff	2025-09-02	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	Rite Aid Corporation	876b80a3-3ea8-4821-9716-c18e24502822	2025-08-20	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868 ndc (product): 11822-3315
Nicotine Mini	NICOTINE POLACRILEX	Rugby Laboratories, Inc.	be17cbe9-43bb-424e-9d91-fba4f02691bb	2025-07-18	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	Chain Drug Consortium, LLC	380ce6c2-3e29-4bdf-a600-f6990925a307	2025-06-30	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	ATLANTIC BIOLOGICALS CORP.	31e0dadd-2678-4e3c-9e62-e3766c21ce5f	2025-06-27	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	ATLANTIC BIOLOGICALS CORP.	a0fc3eae-9c34-48af-bdd2-d95e91b68a9c	2025-06-27	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Nicotine Mini	NICOTINE POLACRILEX	PLD Acquisitions LLC DBA Avma Pharma Solutions	71db232e-b169-47d0-b269-5e14fa75f3a2	2025-03-27	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC)	9b1d9efc-f74b-42f5-be84-5142ee168767	2025-01-30	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	AmerisourceBergen (Good Neighbor Pharmacy) 46122	7f1cdc21-d213-4ede-86fd-e11b31dfab58	2025-01-30	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868
Mini Nicotine	NICOTINE POLACRILEX	Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	4856d5df-3b77-465e-b6a9-38d00854f967	2023-10-23	Warnings	Exact identifier application applno (ANDA): 207868 application number: ANDA207868

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6M3C89ZY6R	NICOTINE	54-11-5	NICOTINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
359817	nicotine 2 MG Oral Lozenge	PSN	876b80a3-3ea8-4821-9716-c18e24502822	4
359817	nicotine 2 MG Oral Lozenge	SCD	876b80a3-3ea8-4821-9716-c18e24502822	4
359817	nicotine 2 MG (as nicotine polacrilex 11.1 MG) Oral Lozenge	SY	876b80a3-3ea8-4821-9716-c18e24502822	4
359817	nicotine 2 MG Troche	SY	876b80a3-3ea8-4821-9716-c18e24502822	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
11822-3315-1	11822331501	3 BOTTLE, PLASTIC in 1 BOX (11822-3315-1) / 27 LOZENGE in 1 BOTTLE, PLASTIC	2019-12-27	2026-12-27	No	No	Current